Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Passarelli
Observed name:
Passarelli, Anna
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0000-0003-4643-7809
Observed ORCID:
0000-0003-4643-7809
OpenAlex ID:
A5136159602
Current management and investigational therapeutic strategies in penile squamous cell carcinoma: A narrative review
2026
·
Lorenzo Lobianco
, Gabriele Calvanese
, et al.
·
Critical Reviews in Oncology/Hematology
PDF
Pragmatic cluster-randomised trial of a multidomain intervention to prevent hospital-acquired disability: the OPTIMAge-IT study protocol
2026
·
Chukwuma Okoye
, Maria Cristina Ferrara
, et al.
·
BMC Geriatrics
Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a multicenter analysis from the Campania Oncological Network (ROC)
2026
·
Rosa Tambaro
, Gabriele Calvanese
, et al.
·
BMC Cancer
Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network
2026
·
Marilena Di Napoli
, Elisabetta Coppola
, et al.
·
Current Oncology
PIK3CA mutations in advanced or recurrent endometrial cancer: an exploratory molecular profiling from the phase II MITO END-3 study.
2026
·
Passarelli, Anna
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type